期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 105, 期 48, 页码 19012-19017出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0807274105
关键词
bioluminescence resonance energy transfer (BRET); estrogenic ligands; selective estrogen receptor modulator (SERM); heterodimer; homodimer
资金
- National Institutes of Health [T32 CA009135, R01CA125387]
Estrogen receptor (ER) dimerization is prerequisite for its activation of target gene transcription. Because the two forms of ER, ER alpha and ER beta, exhibit opposing functions in cell proliferation, the ability of ligands to induce ER alpha/beta heterodimers vs. their respective homodimers is expected to have profound impacts on transcriptional outcomes and cellular growth. However, there is a lack of direct methods to monitor the formation of ER alpha/beta heterodimers in vivo and to distinguish the ability of estrogenic ligands to promote ER homo- vs. heterodimerization. Here, we describe bioluminescence resonance energy transfer (BRET) assays for monitoring the formation of ER alpha/beta heterodimers and their respective homodimers in live cells. We demonstrate that although both partners contribute to heterodimerization, ligand-bound ERa plays a dominant role. Furthermore, a bioactive component was found to induce ER beta/beta homodimers, and ER alpha/beta heterodimers but had minimal activity on ER alpha/alpha homodimers, posing a model that compounds promoting ER alpha/beta heterodimer formation might have therapeutic value. Thus, ER homodimer and heterodimer BRET assays are applicable to drug screening for dinner-selective selective ER modulators. Furthermore, this strategy can be used to study other nuclear receptor dinners.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据